Second Sight Medical Products logo
Second Sight Medical Products EYES
$ 4.1 -0.97%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Second Sight Medical Products Balance Sheet 2011-2024 | EYES

Annual Balance Sheet Second Sight Medical Products

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - -977 K -8.72 M -4.47 M -604 K -539 K -239 K -619 K 19.1 M 8.18 M -

Long Term Debt

19.3 M - 902 K - - - - - - - 19.2 M 8.27 M -

Long Term Debt Current

1.38 M 955 K 910 K - 237 K - - - - - - - -

Total Non Current Liabilities

- - - - 2.36 M - - - - - 19.2 M 8.27 M -

Total Current Liabilities

5.72 M 6.82 M 2.09 M 5.13 M 6.96 M 7.6 M 6.62 M 5.66 M 7.98 M - - - -

Total Liabilities

25 M 6.82 M 2.99 M 5.13 M 9.32 M 7.6 M 6.62 M 5.66 M 7.98 M 8.45 M 21.9 M 11 M -

Deferred Revenue

- - - 335 K 335 K 167 K 48 K 189 K 2.52 M 4.67 M 68.9 K 167 K -

Retained Earnings

-98.4 M -72.8 M -58.9 M -320 M -305 M -269 M -234 M -206 M -173 M -153 M -117 M -94.5 M -

Total Assets

45.8 M 51.1 M 5.45 M 4.46 M 16.6 M 10.7 M 14.5 M 16.8 M 28.2 M 43.1 M 12.7 M 7.99 M -

Cash and Cash Equivalents

20.7 M 45.1 M - 3.18 M 11.3 M 4.47 M 7.84 M 539 K 239 K 619 K - - -

Book Value

20.8 M 44.3 M 2.46 M -672 K 7.28 M 3.08 M 7.88 M 11.1 M 20.3 M 34.6 M -9.22 M -3.04 M -

Total Shareholders Equity

20.8 M 44.3 M 2.46 M -672 K 7.28 M 3.08 M 7.88 M 11.1 M 20.3 M 34.6 M -9.22 M - -

All numbers in USD currency

Quarterly Balance Sheet Second Sight Medical Products

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

18.3 M 18.6 M 18.9 M 19.3 M 19.7 M 20.1 M 349 K - 42 K - - 902 K 102 K 151 K 199 K - - - - 2.36 M 2.36 M 2.36 M 2.36 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

24.6 M 24.4 M 25.1 M 25 M 27.1 M 27.2 M 6.21 M 6.82 M 5.66 M 2.59 M 2.38 M 2.99 M 4.02 M 3.81 M 7.14 M 5.13 M 5.13 M 5.13 M 5.13 M 9.32 M 9.32 M 9.32 M 9.32 M 7.6 M 7.6 M 7.6 M 7.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - 335 K 335 K 335 K 335 K 335 K 335 K 335 K 335 K 335 K 335 K 335 K 335 K 335 K 335 K 167 K 167 K 167 K 167 K 48 K 64 K 147 K 369 K 85 K 85 K 85 K 85 K 322 K 322 K 322 K 322 600 K 600 K 600 K 600 K - - - - - - - - - - - -

Retained Earnings

-116 M -110 M -104 M -98.4 M -92.4 M -85.6 M -79.1 M -72.8 M -65.5 M -334 M -331 M -58.9 M -327 M -325 M -323 M -320 M -320 M -320 M -320 M -305 M -305 M -305 M -305 M -269 M -269 M -269 M -269 M -234 M -234 M -234 M -234 M -206 M -206 M -206 M -206 M -173 M -173 M -173 M -173 K -153 M -153 M -153 M -153 M - - - - - - - - - - - -

Total Assets

42.9 M 48.2 M 53.8 M 45.8 M 53.3 M 59.6 M 44.6 M 51.1 M 57 M 65.6 M 68.5 M 5.45 M 73.6 M 75.9 M 28.1 M 4.46 M 4.46 M 4.46 M 4.46 M 16.6 M 16.6 M 16.6 M 16.6 M 10.7 M 10.7 M 10.7 M 10.7 M 14.5 M 14.5 M 14.5 M 14.5 M 16.8 M 16.8 M 16.8 M 16.8 M 28.2 M 28.2 M 28.2 M 28.2 K 43.1 M 43.1 M 43.1 M 43.1 M - - - - - - - - - - - -

Cash and Cash Equivalents

19.6 M 24.9 M 29.6 M 20.7 M 24.8 M 32.5 M 38.1 M 45.1 M 51.7 M 56.4 M 59.6 M 2.18 M 1.18 M 73.8 M 26.7 M 3.18 M 3.18 M 3.18 M 3.18 M 11.3 M 11.3 M 11.3 M 11.3 M 4.47 M 4.47 M 4.47 M 4.47 M 7.84 M 7.84 M 7.84 M 23.9 M 10.9 M 539 K 539 K 459 16 M 269 K 407 K 239 619 619 K 619 K 619 K 62 K - - - 145 K - - - - - - -

Book Value

18.3 M 23.8 M 28.7 M 20.8 M 26.2 M 32.4 M 38.4 M 44.3 M 51.4 M 63.1 M 66.2 M 2.46 M 69.6 M 72.1 M 21 M -672 K -672 K -672 K -672 K 7.28 M 7.28 M 7.28 M 7.28 M 3.08 M 3.08 M 3.08 M 3.08 M 14.5 M 14.5 M 14.5 M 14.5 M 16.8 M 16.8 M 16.8 M 16.8 M 28.2 M 28.2 M 28.2 M 28.2 K 43.1 M 43.1 M 43.1 M 43.1 M - - - - - - - - - - - -

Total Shareholders Equity

18.3 M 23.8 M 28.7 M 20.8 M 26.2 M 32.4 M 38.4 M 44.3 M 51.4 M -4.82 M -1.12 M 2.46 M 1.43 M 1.4 M 1.6 M -672 K -672 K -672 K -672 K 7.28 M 7.28 M 7.28 M 7.28 M 3.08 M 3.08 M 3.08 M 3.08 M 7.88 M 7.88 M 7.88 M 7.88 M 11.1 M 11.1 M 11.1 M 11.1 M 20.3 M 24.5 M 28.1 M 20.3 K 34.6 M 34.6 M 34.6 M 34.6 M -9.22 M - - - -3.04 M - - - - - - -

All numbers in USD currency